BIOMAT Database Logo BIOMAT Database Logo

[Enzymatic estimation of infarct size in patients undergoing thrombolytic therapy]. 1988

G Melandri, and F Tartagni, and A Branzi, and C Berardi, and F Bruscoli, and N Monetti, and B Magnani

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D004796 Clinical Enzyme Tests Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status. Enzyme Tests, Clinical,Clinical Enzyme Test,Enzyme Test, Clinical,Test, Clinical Enzyme,Tests, Clinical Enzyme
D005260 Female Females
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G Melandri, and F Tartagni, and A Branzi, and C Berardi, and F Bruscoli, and N Monetti, and B Magnani
Does thrombolytic therapy reduce infarct size?
May 1989, Journal of the American College of Cardiology,
G Melandri, and F Tartagni, and A Branzi, and C Berardi, and F Bruscoli, and N Monetti, and B Magnani
Enzymatic estimation of infarct size during reperfusion.
August 1983, Circulation,
G Melandri, and F Tartagni, and A Branzi, and C Berardi, and F Bruscoli, and N Monetti, and B Magnani
Electrocardiographic measurement of infarct size after thrombolytic therapy.
March 1996, Journal of the American College of Cardiology,
G Melandri, and F Tartagni, and A Branzi, and C Berardi, and F Bruscoli, and N Monetti, and B Magnani
Enzymatic infarct size and its significance for evaluation of thrombolytic therapy after acute myocardial infarction.
May 1990, Circulation,
G Melandri, and F Tartagni, and A Branzi, and C Berardi, and F Bruscoli, and N Monetti, and B Magnani
[Infarct size and left ventricular function in patients after thrombolytic therapy of acute myocardial infarct].
June 1989, Vnitrni lekarstvi,
G Melandri, and F Tartagni, and A Branzi, and C Berardi, and F Bruscoli, and N Monetti, and B Magnani
A sensitivity analysis of enzymatic estimation of infarct size.
July 1975, Circulation,
G Melandri, and F Tartagni, and A Branzi, and C Berardi, and F Bruscoli, and N Monetti, and B Magnani
An improved basis for enzymatic estimation of infarct size.
November 1975, Circulation,
G Melandri, and F Tartagni, and A Branzi, and C Berardi, and F Bruscoli, and N Monetti, and B Magnani
Correlation between enzymatic estimation of infarct size and early mortality rate.
December 1983, British heart journal,
G Melandri, and F Tartagni, and A Branzi, and C Berardi, and F Bruscoli, and N Monetti, and B Magnani
[Dynamic characteristics of the electrocardiographic and biochemical indices in myocardial infarct patients undergoing thrombolytic therapy].
January 1987, Terapevticheskii arkhiv,
G Melandri, and F Tartagni, and A Branzi, and C Berardi, and F Bruscoli, and N Monetti, and B Magnani
[Dynamic function of the recanalized coronary artery in patients with myocardial infarct undergoing thrombolytic therapy].
January 1989, Terapevticheskii arkhiv,
Copied contents to your clipboard!